These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6101081)

  • 21. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV; Medzihradsky F
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.
    Perry DC; Rosenbaum JS; Kurowski M; Sadée W
    Mol Pharmacol; 1982 Mar; 21(2):272-9. PubMed ID: 6285166
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for a stereospecific [3H]etorphine binding in human placenta.
    Valette A; Pontonnier G; Cros J
    FEBS Lett; 1979 Jul; 103(2):362-5. PubMed ID: 223886
    [No Abstract]   [Full Text] [Related]  

  • 25. Opiate receptors in the rat brain. Specific labeling of multiple membrane components with [3H]etorphine?
    Puget A; Jauzac P; Zajac JM; Meunier JC
    Mol Pharmacol; 1981 Sep; 20(2):263-8. PubMed ID: 6272085
    [No Abstract]   [Full Text] [Related]  

  • 26. Opioid inhibition of dopamine release from nervous tissue of Mytilus edulis and Octopus bimaculatus.
    Stefano GB; Hall B; Makman MH; Dvorkin B
    Science; 1981 Aug; 213(4510):928-30. PubMed ID: 6266017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
    Gouardéres C; Audigier Y; Cros J
    Eur J Pharmacol; 1982 Mar; 78(4):483-6. PubMed ID: 6281039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of opiate receptors within visual structures of the cat brain.
    Walker JM; Bowen WD; Thompson LA; Frascella J; Lehmkuhle S; Hughes HC
    Exp Brain Res; 1988; 73(3):523-32. PubMed ID: 2852119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
    Kooper GN; Levinson NR; Copeland CF; Bowen WD
    Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascorbate inhibits specific binding of etorphine and low Km GTPase in NG108-15 hybrid cells.
    Bhatia M; Ralhan R; Sharma SK
    Indian J Biochem Biophys; 1988 Dec; 25(6):699-702. PubMed ID: 2855630
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo binding of 3H-etorphine in morphine-dependent rats.
    Perry DC; Rosenbaum JS; Sadee W
    Life Sci; 1982 Sep 20-27; 31(12-13):1405-8. PubMed ID: 6292637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
    Jauzac P; Puget A; Meunier JC
    Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid induction of immunoreactive interleukin-1 in Mytilus edulis and human immunocytes: an interleukin-1-like substance in invertebrate neural tissue.
    Stefano GB; Smith EM; Hughes TK
    J Neuroimmunol; 1991 Apr; 32(1):29-34. PubMed ID: 2002089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct molecular forms of opiate binding in the frog brain.
    Puget A; Jauzac P; Meunier JC
    Life Sci; 1983; 33 Suppl 1():199-202. PubMed ID: 6319860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of etorphine brain concentrations and changes in etorphine-naloxone pA2 values in morphine-pretreated mice.
    Lange DG; Roerig SC; Fujimoto JM; Wang RI
    Biochem Pharmacol; 1981 Jan; 30(2):147-55. PubMed ID: 7236304
    [No Abstract]   [Full Text] [Related]  

  • 40. The adenylate cyclase rebound response to naloxone in the NG108-15 cells. Effects of etorphine and other opiates.
    Musacchio JM; Greenspan DL
    Neuropharmacology; 1986 Aug; 25(8):833-7. PubMed ID: 3022177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.